Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.

Revenue projections:

Revenue projections for APOLLOHOSP
Revenue projections for APOLLOHOSP

With APOLLOHOSP's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.

Financial Ratios:

currentRatio 0.000000
forwardPE 52.161842
debtToEquity 93.132000
earningsGrowth 0.518000
revenueGrowth 0.139000
grossMargins 0.347040
operatingMargins 0.104380
trailingEps 91.250000
forwardEps 81.600000

Apollo Hospitals Enterprise Limited's forward PE is too high, potentially limiting future gains and posing a risk of a price correction. This valuation must be carefully considered with other fundamental metrics to evaluate whether the stock is worth its current price.
Apollo Hospitals Enterprise Limited's elevated debt-to-equity ratio shows that the company is relying heavily on debt to fund its activities. This high leverage can amplify returns but also heightens financial risks if cash flow becomes constrained.
Positive earnings and revenue growth for APOLLOHOSP point to expected business expansion. The company is projected to continue growing its operations, as increasing profits and sales highlight a strong trajectory for further growth in the future.
With forward EPS less than trailing EPS, APOLLOHOSP is expected to see reduced earnings. This suggests the company may face profitability challenges in the current financial year compared to the previous one.

Price projections:

Price projections for APOLLOHOSP
Price projections for APOLLOHOSP

Apollo Hospitals Enterprise Limited's price has consistently hovered around the lower end of analysts' projections. This pattern may reflect concerns regarding the company's ability to achieve its anticipated growth.

Insider Transactions:

Insider Transactions for APOLLOHOSP
Insider Transactions for APOLLOHOSP


3 purchases of Apollo Hospitals Enterprise Limited were executed, with market price of 6553.183268229167.No buy transactions took place in the period under consideration.APOLLOHOSP has seen more sells at current price levels, which could indicate a potential decline. If this trend continues, investors may expect the stock's price to drop further as more people exit their positions.

Recommendation changes over time:

Recommendations trend for APOLLOHOSP
Recommendations trend for APOLLOHOSP


APOLLOHOSP has recently received a buy bias from analysts, indicating that the stock is being perceived as a favorable investment. This positive sentiment could encourage investors to see APOLLOHOSP as a wise place to allocate their funds, potentially leading to increased interest in the company's stock.